FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Sun Pharma Global Venlafaxine Hydrochloride Extended-Release Recall

Venlafaxine Hydrochloride Extended-Release Tablets, 37

Sun Pharma Global Inc. · Dubai, N/A

Risk level
Class II
Reported by FDA
Nov 12, 2014
Recall ID
D-0236-2015
Check your lot numberHow we source this data

Summary

Sun Pharma Global recalled Venlafaxine Hydrochloride Extended-Release starting Sep 26, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0236-2015 on Nov 12, 2014. Reason: Failed Dissolution Specifications; 12 month stability time point. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications; 12 month stability time point

Product description

Venlafaxine Hydrochloride Extended-Release Tablets, 37.5 mg, 30-count bottles and 90-count bottles, RX only, Manufactured for Sun Pharma Global Inc. Dubai, United Arab Emirates by Sun Pharmaceutical Industries Limited, Halol, India

Lot numbers, UPCs & expiration codes

Batch Number: JKM3855A Mfg. Date: 06/25/2013 Exp. Date: 05/31/2015 Batch Number: JKM3855B Mfg. Date: 06/25/2013 Exp. Date: 05/31/2015 Batch Number: JKM7265A Mfg. Date: 12/25/2013 Exp. Date: 11/30/2015 Batch Number: JKM7265B Mfg. Date: 12/25/2013 Exp. Date: 11/30/2015

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0236-2015
Classification
Class II
Status
Terminated
Recall initiated
Sep 26, 2014
FDA report date
Nov 12, 2014
Quantity
68194
Recall type
Voluntary: Firm initiated
Recalling firm
Sun Pharma Global Inc.

Original FDA data

Every field from FDA enforcement report D-0236-2015, exactly as published.

Show all FDA fields
City
Dubai
Status
Terminated
Country
United Arab Emirates
Event ID
69370
Address
P.O. Box 12850
Code information
Batch Number: JKM3855A Mfg. Date: 06/25/2013 Exp. Date: 05/31/2015 Batch Number: JKM3855B Mfg. Date: 06/25/2013 Exp. Date: 05/31/2015 Batch Number: JKM7265A Mfg. Date: 12/25/2013 Exp. Date: 11/30/2015 Batch Number: JKM7265B Mfg. Date: 12/25/2013 Exp. Date: 11/30/2015
Report date
Nov 12, 2014
Product type
Drugs
Recall number
D-0236-2015
Classification
Class II
Recalling firm
Sun Pharma Global Inc.
Product quantity
68194
Termination date
May 6, 2015
Reason for recall
Failed Dissolution Specifications; 12 month stability time point
Voluntary / mandated
Voluntary: Firm initiated
Product description
Venlafaxine Hydrochloride Extended-Release Tablets, 37.5 mg, 30-count bottles and 90-count bottles, RX only, Manufactured for Sun Pharma Global Inc. Dubai, United Arab Emirates by Sun Pharmaceutical Industries Limited, Halol, India
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Sep 26, 2014
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Nov 4, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0236-2015, published Nov 12, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls